Business Description
Onward Medical NV
ISIN : NL0015000HT4
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.85 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 0.94 | |||||
Debt-to-EBITDA | -0.51 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 24.3 | |||||
3-Year EPS without NRI Growth Rate | 29.3 | |||||
3-Year FCF Growth Rate | 21.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 9.93 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.67 | |||||
9-Day RSI | 58.62 | |||||
14-Day RSI | 56.09 | |||||
6-1 Month Momentum % | 7.13 | |||||
12-1 Month Momentum % | 64.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.65 | |||||
Quick Ratio | 3.65 | |||||
Cash Ratio | 3.36 | |||||
Days Payable | 1557.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -72.3 | |||||
Shareholder Yield % | -9.62 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -149.47 | |||||
ROA % | -70.53 | |||||
ROIC % | -269.31 | |||||
3-Year ROIIC % | -322.05 | |||||
ROC (Joel Greenblatt) % | -1776.58 | |||||
ROCE % | -82.73 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 9.66 | |||||
Price-to-Tangible-Book | 22.61 | |||||
EV-to-EBIT | -5.95 | |||||
EV-to-EBITDA | -6.1 | |||||
EV-to-FCF | -7.42 | |||||
Price-to-Net-Current-Asset-Value | 30.59 | |||||
Price-to-Net-Cash | 57.78 | |||||
Earnings Yield (Greenblatt) % | -16.81 | |||||
FCF Yield % | -13.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Onward Medical NV Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.09 | ||
Beta | 0.58 | ||
Volatility % | 48.14 | ||
14-Day RSI | 56.09 | ||
14-Day ATR (€) | 0.215155 | ||
20-Day SMA (€) | 5.0775 | ||
12-1 Month Momentum % | 64.24 | ||
52-Week Range (€) | 1.995 - 6.54 | ||
Shares Outstanding (Mil) | 44.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Onward Medical NV Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Onward Medical NV Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Onward Medical NV Frequently Asked Questions
What is Onward Medical NV(FRA:63E)'s stock price today?
When is next earnings date of Onward Medical NV(FRA:63E)?
Does Onward Medical NV(FRA:63E) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |